Jack Cuzick, PhD, FRS, FMedSci, FRCP, professor of epidemiology at Queen Mary University of London, reflects on his career in conversation with SABCS Co-Director Virginia Kaklamani, MD.

Sherene Loi, MBBS, FRACP, PhD, FAHMS, head of translational breast cancer genomics and therapeutics lab at the University of Melbourne, and Virginia Kaklamani, MD, leader of the breast medical oncology program at Mays Cancer Center at UT Health San Antonio, discuss the options of treating ER positive breast with immunotherapy.

Hatem Azim, MD, chief medical officer at Emergence Therapeutics, and Marcela Mazo Canola, MD, breast medical oncologist at Mays Cancer Center at UT Health San Antonio, discuss if patients can interrupt endocrine therapy to attempt pregnancy.

Anne May, PhD, professor of clinical epidemiology of cancer survivorship at UMC Utrecht, and Lindsay Peterson, MD, MSCR, assistant professor of medicine for division of oncology at Cancer and Aging Research Group, discuss the effects of a structured and individualized exercise program on fatigue and health-related quality of life in patients with metastatic breast cancer.

Reshma Jagsi, MD, DPhil, department chair for radiation oncology at Emory University School of Medicine, and Richard Zellers, MD, department chair for radiation oncology at Indiana University School of Medicine, discuss endocrine therapy without radiotherapy after breast-conserving surgery for postmenopausal patients with genomically-selected favorable Stage I breast cancer.

Debra Pratt, MD, PhD, MBA, FASCO, executive vice president of Texas Oncology and clinical professor at the Dell Medical School at the University of Texas at Austin, discusses controversies in local regional care with Symposium Program Director Kate Lathrop, MD.